305 related articles for article (PubMed ID: 26555174)
1. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
[TBL] [Abstract][Full Text] [Related]
2. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
[TBL] [Abstract][Full Text] [Related]
3. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M
Cancer Cell; 2007 Feb; 11(2):119-32. PubMed ID: 17292824
[TBL] [Abstract][Full Text] [Related]
4. NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions.
Vlantis K; Wullaert A; Polykratis A; Kondylis V; Dannappel M; Schwarzer R; Welz P; Corona T; Walczak H; Weih F; Klein U; Kelliher M; Pasparakis M
Immunity; 2016 Mar; 44(3):553-567. PubMed ID: 26982364
[TBL] [Abstract][Full Text] [Related]
5. Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB.
Webb LV; Barbarulo A; Huysentruyt J; Vanden Berghe T; Takahashi N; Ley S; Vandenabeele P; Seddon B
Immunity; 2019 Feb; 50(2):348-361.e4. PubMed ID: 30737145
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.
Annibaldi A; Wicky John S; Vanden Berghe T; Swatek KN; Ruan J; Liccardi G; Bianchi K; Elliott PR; Choi SM; Van Coillie S; Bertin J; Wu H; Komander D; Vandenabeele P; Silke J; Meier P
Mol Cell; 2018 Feb; 69(4):566-580.e5. PubMed ID: 29452637
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
10. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.
Van TM; Polykratis A; Straub BK; Kondylis V; Papadopoulou N; Pasparakis M
J Clin Invest; 2017 Jun; 127(7):2662-2677. PubMed ID: 28628031
[TBL] [Abstract][Full Text] [Related]
11. NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.
Kumari S; Van TM; Preukschat D; Schuenke H; Basic M; Bleich A; Klein U; Pasparakis M
Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33858959
[TBL] [Abstract][Full Text] [Related]
12. Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1.
Hsin IF; Montano E; Seki E
Hepatology; 2016 Jul; 64(1):295-7. PubMed ID: 27122117
[No Abstract] [Full Text] [Related]
13. OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- and RIPK1 Kinase-Mediated Hepatocyte Apoptosis.
Verboom L; Martens A; Priem D; Hoste E; Sze M; Vikkula H; Van Hove L; Voet S; Roels J; Maelfait J; Bongiovanni L; de Bruin A; Scott CL; Saeys Y; Pasparakis M; Bertrand MJM; van Loo G
Cell Rep; 2020 Feb; 30(7):2237-2247.e6. PubMed ID: 32075762
[TBL] [Abstract][Full Text] [Related]
14. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury.
Krishna-Subramanian S; Singer S; Armaka M; Banales JM; Holzer K; Schirmacher P; Walczak H; Kollias G; Pasparakis M; Kondylis V
Cell Death Differ; 2019 Dec; 26(12):2710-2726. PubMed ID: 30988397
[TBL] [Abstract][Full Text] [Related]
15. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.
Wong WW; Gentle IE; Nachbur U; Anderton H; Vaux DL; Silke J
Cell Death Differ; 2010 Mar; 17(3):482-7. PubMed ID: 19927158
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
[TBL] [Abstract][Full Text] [Related]
17. HBx-induced NF-κB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO.
Lim KH; Choi HS; Park YK; Park ES; Shin GC; Kim DH; Ahn SH; Kim KH
PLoS One; 2013; 8(3):e57331. PubMed ID: 23483900
[TBL] [Abstract][Full Text] [Related]
18. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration.
Malato Y; Sander LE; Liedtke C; Al-Masaoudi M; Tacke F; Trautwein C; Beraza N
Hepatology; 2008 Jun; 47(6):2036-50. PubMed ID: 18393321
[TBL] [Abstract][Full Text] [Related]
20. RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer.
Schneider AT; Gautheron J; Feoktistova M; Roderburg C; Loosen SH; Roy S; Benz F; Schemmer P; Büchler MW; Nachbur U; Neumann UP; Tolba R; Luedde M; Zucman-Rossi J; Panayotova-Dimitrova D; Leverkus M; Preisinger C; Tacke F; Trautwein C; Longerich T; Vucur M; Luedde T
Cancer Cell; 2017 Jan; 31(1):94-109. PubMed ID: 28017612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
